Global Hyaluronic Acid Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027Price: 3200/- USD | Published Date: September 12, 2020 |
The global hyaluronic acid market has been projected to grow at the CAGR of 9% market during 2020-2027. In 2019, the market has generated the revenue of $ 8.3 billion and is expected to reach $ 13.4 billion in terms of revenue by 2025.
Increasing demand relating to anti-aging processes has resulted in increase in demand for global hyaluronic acid market. Hyaluronic acid, also known as hyaluronan, are organic compounds belonging to the branch of carbohydrates and further to its polysaccharides segment. Hyaluronic acid is prepared in laboratory by various processes including extraction from rooster combs, in-vitro and bacterial production. It is a non-sulfated glycosaminoglycan which is present in the connective, neural and epithelial tissues of living organisms. Owing to its hydrophilic nature, hyaluronic acid is used as lubricant and shock absorber in various joint disorders, including osteoarthritis. However, it can be injected into the affected joint or taken by mouth as per directed by healthcare professional.
The hyaluronic acid market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The increasing geriatric population, growing awareness about anti-aging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficiency and evident results of hyaluronic acid-based dermal fillers are attracting this population base. The rapid growth of aging population and substantial increase of the disease conditions such as ulcers, osteoarthritis, and dry eyes are the key factors boosting the demand. Global aged population was nearly 809.4 million and is expected to reach an estimated population of over 2.0 billion. More than 29 million individuals are suffering from osteoarthritis and a large population above 60 years of age is now prone to develop symptomatic knee osteoarthritis. Use of hyaluronan as a treatment for osteoarthritis has been approved by U.S. FDA in 1997 and has gained substantial share in the global market. The industry is witnessing introduction of newer technology and geographical expansion through approvals and mergers & acquisitions done by the industry titans.
Market Segment Insights:
The product type segments covered in the study include single, three and five injections. Five injections is the largest application segment for hyaluronic acid. It accounted for 40% share of the market in 2016 in terms of revenue. The market is mainly driven by high usage associated with it. Single injection segment is projected to be the highest growth segment of the market, which is primarily driven by the benefits associated with it. The application segments include vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis. Dermal fillers is the largest application segment for hyaluronic acid. It accounted for 37% share of the market in 2016 in terms of revenue. Vesicoureteral reflux segment is projected to be the highest growth segment of the market.
Global Hyaluronic Acid Market Segmentation:
By Product, 2018–2027 ($ Millon)
- Single Injection
- Three Injection
- Five Injections
By Application, 2018–2028 ($ Millon)
- Dermal Fillers
- Vesicoureteral Reflux (VUR)
By Geography, 2018-2027 ($ Millon)
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
North America is the largest market for hyaluronic acid and accounted for 38% share of the market in 2014. The market is primarily boosted by growing aged population and their treatment needs. North America is projected to maintain its dominance during the forecast period. Asia Pacific is projected to be the fastest growing market for hyaluronic acid products. Growing awareness among the population and enhancement in health care infrastructure is the major factor attributing towards the market growth.
Market Competition Assessment:
The major players currently operating in the global hyaluronic acid market include Anika Therapeutics, Inc., Allergan plc, Sanofi S.A., Ferring B.V., Seikagaku Corporation, AstraZeneca, Salix Pharmaceutical, Inc., Fidia Farmaceutici, and Zimmer Biomet.
List of Key Companies:
- Allergan plc
- Anika Therapeutics, Inc.
- Ferring B.V.
- Fidia Farmaceutici
- Salix Pharmaceutical, Inc.
- Sanofi S.A.
- Seikagaku Corporation
- Uhde Inventa – Fischer
- Zimmer Biomet
Key Questions Answered by Hyaluronic Acid Market Report
- Global hyaluronic acid market forecasts from 2020-2027
- Regional hyaluronic acid market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
- Hyaluronic Acid submarket forecasts from 2020-2027 covering submarket 1, submarket 2 submarket 3
- Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to hyaluronic acid market
- Analysis of the key factors driving and restraining the growth of the global, regional and country level hyaluronic acid markets from 2020-2027
- Competitive Landscape and market positioning of top 10 players operating in the hyaluronic acid market
Request a full report sample @ https://www.researchcorridor.com/request-sample/?id=74698
Table of Content:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Hyaluronic Acid Market Portraiture
2.2 Global Hyaluronic Acid Market, by Product, 2019 ($ Million)
2.3 Global Hyaluronic Acid Market, by Application, 2019 ($ Million)
2.4 Global Hyaluronic Acid Market, by Geography, 2019 (Value %)
Chapter 3 Global Hyaluronic Acid Market Analysis
3.1 Global Hyaluronic Acid Market Overview
3.2 Major Market Trends and Key Takeaways
3.3 Market Dynamics
3.3.1 Market Drivers
220.127.116.11 Increasing use of hyaluronic acid in treatments of dry eyes, mouth sores, and aging skin is expected to drive the market growth
18.104.22.168 Substitution from cost-effective treatments along with several regulations concerns to restrain the market growth
3.4 Attractive Investment Proposition
3.5 Competitive Analysis: Global Hyaluronic Acid Market, 2019 (Value %)
Chapter 4 Global Hyaluronic Acid Market, by Product, 2018-2027 ($ Million)
4.2 Single Injection
4.3 Three Injection
4.4 Five Injections
Chapter 5 Global Hyaluronic Acid Market, by Application, 2018-2027 ($ Million)
5.2 Dermal Fillers
5.5 Vesicoureteral Reflux (VUR)
Chapter 6 Global Hyaluronic Acid Market, by Geography, 2018-2027 ($ Million)
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, Singapore, South Korea and Rest of APAC)
6.5 Latin America (Mexico, Brazil and Rest of LATAM)
6.6 Middle East and Africa (GCC, and Rest of Middle East and Africa)
Chapter 7 Company Profiles
7.1 Anika Therapeutics, Inc.
7.2 Allergan plc
7.3 Sanofi S.A.
7.4 Ferring B.V.
7.5 Seikagaku Corporation
7.7 Salix Pharmaceutical, Inc.
7.8 Fidia Farmaceutici
7.9 Zimmer Biomet
$4800/- Multi User License $6400/- Corporate License
- Markets in over 150 countries analyzed granularly
- 35% of our total client are returning clients
- 100,000+ data points in our comprehensive database
- 24x5 availability - we are always there when you need us
- Our expert team will assist you with all research need and customization
- Our expert research analysts will resolve your every query before and after purchasing the report
- We focus on the accuracy and quality of the report
- Our analyst will provide deep insights into the report
Call Us: +1 520-686-7060